NVAX Earnings: Novavax Soars After Stellar Growth in Revenue, Sanofi Deal Boost – TipRanks.com TipRanksNovavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal Yahoo FinanceNovavax (NVAX) Biggest Surge Since 2009 Burns Shorts for $255 Million BloombergNovavax shares spike over 100% on Sanofi deal to commercialize Covid vaccine, develop combination shots CNBCNovavax shares more than double on Sanofi’s $1.4 billion investment for combo vaccine MarketWatch